Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
Ozempic vs Wegovy is one of the most searched comparisons in the GLP-1 space — and the confusion is completely understandable. Here is the definitive explanation.
Same Drug, Different Doses and Approvals
Both Ozempic and Wegovy are manufactured by Novo Nordisk and contain semaglutide. The distinction is regulatory, not chemical. Ozempic was first approved in 2017 for type 2 diabetes management at doses up to 1mg weekly (later expanded to 2mg). Wegovy was approved in 2021 for chronic weight management at a maximum dose of 2.4mg weekly — a higher dose specifically studied for weight loss outcomes in non-diabetic obese patients.
Why the Higher Dose Matters for Weight Loss
The dose difference is clinically significant. At 1mg (Ozempic diabetes dose), average weight loss is 3–6% of body weight. At 2.4mg (Wegovy dose), average weight loss is approximately 15%. The higher dose produces stronger and more sustained appetite suppression. This is why Wegovy was created as a separate product — to have a weight-management-specific dose with its own trial programme and approval.
The Prescribing Grey Zone
Physicians frequently prescribe Ozempic off-label for weight loss in non-diabetic patients — technically prescribing the diabetes drug for a weight indication. This is legal and extremely common. The clinical effect is the same; only the regulatory label differs. Some insurers will not cover Ozempic for weight loss (only Wegovy), and some will not cover Wegovy at all. This inconsistency drives many patients toward compounded semaglutide.
Compounded Semaglutide: The Practical Unifier
Compounded semaglutide available through telehealth platforms contains the same active ingredient and can be prescribed at any dose — including the Wegovy 2.4mg dose — at a fraction of the brand price. This effectively eliminates the practical distinction between “Ozempic” and “Wegovy” for most patients focused on weight loss, making the brand name largely irrelevant to the clinical outcome.
Which Should You Ask For?
If getting brand-name medication: ask for Wegovy if weight loss is your primary goal and you have no T2D diagnosis; ask for Ozempic if you have T2D (better insurance coverage). If accessing compounded semaglutide: simply discuss your goals with the telehealth physician, who will prescribe the appropriate dose protocol regardless of brand.
Frequently Asked Questions
Q: Is Ozempic the same as Wegovy?
A: Ozempic and Wegovy contain the same active ingredient — semaglutide — but are different products approved for different purposes. Ozempic (0.5mg, 1mg, 2mg) is approved for type 2 diabetes. Wegovy (2.4mg) is approved for chronic weight management. Wegovy uses a higher dose specifically optimised for weight loss.
Q: Can you use Ozempic instead of Wegovy for weight loss?
A: Many physicians prescribe Ozempic off-label for weight loss. It is the same drug and produces the same mechanism of action. The main difference is the approved maximum dose — Wegovy goes to 2.4mg while Ozempic is approved to 2mg for diabetes. Compounded semaglutide bridges this gap by allowing any dose to be prescribed.
Q: Why is Ozempic cheaper than Wegovy?
A: Brand Ozempic and Wegovy have similar list prices ($900-$1,300/month). However, Ozempic more commonly has manufacturer savings cards and better insurance coverage for T2D patients, which can make out-of-pocket costs lower. Compounded semaglutide bypasses both entirely at $149-$299/month.
📖 Further Reading
Get Semaglutide at the Right Dose for Your Goals
Physician-supervised compounded semaglutide from $149/month.
Sponsored | Affiliate link
Affiliate disclosure: This article contains affiliate links. See our Affiliate Disclosure.